finance.foundation / Companies / LLY vs NOVN
Comparison · seed-0.6 · 2026-08-29
Eli Lilly (LLY) vs Novartis (NOVN)
Eli Lilly (LLY) and Novartis (NOVN) side by side: both in Healthcare, listed on New York Stock Exchange and SIX Swiss Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 3.3×).
| Field | Eli Lilly | Novartis |
|---|---|---|
| Legal name | Eli Lilly and Company | Novartis AG |
| Ticker | LLY | NOVN |
| Exchange | New York Stock Exchange XNYS | SIX Swiss Exchange XSWX |
| Jurisdiction | United States | Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $750bn | $230bn |
| Founded | 1876 | 1996 |
| Reporting currency | USD | CHF |
| LEI | FRDRIPF3EKNDJ2CQJL29 | 5493007HIVTX6SY6XD66 |
| ISIN | US5324571083 | CH0012005267 |
| FIGI | BBG001S5STL8 | BBG001SD31N7 |
| Index membership | S&P 500 | — |
| Held by (covered funds) | 1 | — |
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
Novartis
Basel-based pharmaceutical company created by the 1996 merger of Ciba-Geigy and Sandoz, now a pure-play innovative-medicines business after spinning off Alcon and Sandoz. Key franchises include cardiovascular, oncology and immunology drugs.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/eli-lilly · /api/v1/companies/novartis